ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 720 filers reported holding ISHARES TR in Q4 2019. The put-call ratio across all filers is 1.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $201,000 | -7.4% | 1,314 | -27.0% | 0.06% | -42.9% |
| Q4 2019 | $217,000 | -51.6% | 1,801 | -60.0% | 0.10% | -55.3% |
| Q3 2019 | $448,000 | +17.3% | 4,501 | +28.6% | 0.22% | +15.3% |
| Q2 2019 | $382,000 | +0.3% | 3,501 | +2.6% | 0.19% | -12.4% |
| Q1 2019 | $381,000 | +11.1% | 3,411 | -4.2% | 0.22% | -3.6% |
| Q4 2018 | $343,000 | -16.9% | 3,561 | +5.0% | 0.22% | -0.9% |
| Q3 2018 | $413,000 | +7.8% | 3,391 | -2.8% | 0.23% | -2.6% |
| Q2 2018 | $383,000 | +2.4% | 3,490 | -0.4% | 0.23% | +3.6% |
| Q1 2018 | $374,000 | +4.2% | 3,505 | +4.3% | 0.22% | -1.7% |
| Q4 2017 | $359,000 | -4.0% | 3,360 | +200.0% | 0.23% | -16.1% |
| Q3 2017 | $374,000 | +7.8% | 1,120 | 0.0% | 0.27% | +11.0% |
| Q2 2017 | $347,000 | +2.4% | 1,120 | -3.0% | 0.25% | -5.0% |
| Q1 2017 | $339,000 | +11.5% | 1,155 | +0.9% | 0.26% | +7.5% |
| Q4 2016 | $304,000 | +16.0% | 1,145 | +26.5% | 0.24% | +13.7% |
| Q3 2016 | $262,000 | +12.4% | 905 | 0.0% | 0.21% | -4.1% |
| Q2 2016 | $233,000 | – | 905 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |